Safety and Tolerability Study of MCI-196
Clinical trial NCT01818687 · TERMINATED
Trial details
- NCT number
- NCT01818687
- Sponsor
- Tanabe Pharma Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.